Royal Bank of Canada lessened its stake in Astrana Health, Inc. (NASDAQ:ASTH – Free Report) by 97.9% in the first quarter, Holdings Channel.com reports. The institutional investor owned 1,438 shares of the company’s stock after selling 66,556 shares during the quarter. Royal Bank of Canada’s holdings in Astrana Health were worth $35,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently made changes to their positions in ASTH. Swiss National Bank raised its position in shares of Astrana Health by 1.2% during the 3rd quarter. Swiss National Bank now owns 86,944 shares of the company’s stock valued at $2,465,000 after buying an additional 1,000 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of Astrana Health by 5.2% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,768 shares of the company’s stock worth $799,000 after acquiring an additional 1,263 shares during the last quarter. Deutsche Bank AG grew its position in Astrana Health by 3.9% in the fourth quarter. Deutsche Bank AG now owns 41,265 shares of the company’s stock worth $1,024,000 after acquiring an additional 1,550 shares in the last quarter. Price T Rowe Associates Inc. MD grew its position in Astrana Health by 3.8% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 42,258 shares of the company’s stock worth $1,049,000 after acquiring an additional 1,562 shares in the last quarter. Finally, Strs Ohio bought a new position in Astrana Health in the fourth quarter valued at $40,000. Institutional investors own 52.77% of the company’s stock.
Astrana Health Price Performance
ASTH stock opened at $37.83 on Friday. The firm has a market cap of $2.11 billion, a P/E ratio of 46.13 and a beta of 0.90. The firm’s fifty day moving average is $41.07 and its 200 day moving average is $34.62. Astrana Health, Inc. has a 52 week low of $18.08 and a 52 week high of $51.60. The company has a debt-to-equity ratio of 1.05, a quick ratio of 1.23 and a current ratio of 1.23.
Analyst Ratings Changes
A number of research firms have weighed in on ASTH. Truist Financial raised their price target on Astrana Health from $47.00 to $55.00 and gave the company a “buy” rating in a research report on Monday, August 10th. Weiss Ratings reiterated a “hold (c)” rating on shares of Astrana Health in a report on Thursday, August 27th. TD Cowen increased their price objective on Astrana Health from $45.00 to $50.00 and gave the company a “buy” rating in a research report on Tuesday, July 14th. Robert W. Baird set a $45.00 price objective on Astrana Health in a report on Friday, May 8th. Finally, Barclays boosted their target price on Astrana Health from $50.00 to $53.00 and gave the stock an “overweight” rating in a research report on Friday, August 7th. Seven research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $49.43.
Check Out Our Latest Report on ASTH
About Astrana Health
Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.
Featured Articles
- Five stocks we like better than Astrana Health
- The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story
- NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now
- Dropping the Dough: Yum! Brands Strategically Trims the Fat
- These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern
Want to see what other hedge funds are holding ASTH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astrana Health, Inc. (NASDAQ:ASTH – Free Report).
Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.
